CHRDL2 Activators
CHRDL2 Activators encompass a diverse range of chemical compounds that, through their interaction with various cellular pathways, lead to the upregulation and increased functional activity of CHRDL2. Forskolin, by activating adenylyl cyclase, boosts intracellular cAMP, subsequently activating protein kinase A (PKA). PKA then phosphorylates transcription factors thatCHRDL2 Activators encompass a diverse range of chemical compounds that, through their interaction with various cellular pathways, lead to the upregulation and increased functional activity of CHRDL2. Forskolin, by activating adenylyl cyclase, boosts intracellular cAMP, subsequently activating protein kinase A (PKA). PKA then phosphorylates transcription factors that enhance CHRDL2 expression. Similarly, IBMX increases cAMP levels by inhibiting phosphodiesterases, and Epinephrine acts on adrenergic receptors to raise cAMP, both converging on PKA activation and CHRDL2 upregulation. PGE2, through its action on EP receptors, also raises cAMP levels, enhancing CHRDL2 activity. Additionally, Cholera toxin, by permanently activating adenylyl cyclase, causes a sustained cAMP increase, which leads to persistent PKA activation and may enhance CHRDL2 expression and function.
Anisomycin activates JNK signaling, which can modulate transcription factors to upregulate CHRDL2, while Retinoic acid interacts with its nuclear receptors to directly influence genes involved in CHRDL2's activation pathway. Dibutyryl-cAMP (db-cAMP), a cAMP analog, activates PKA, promoting CHRDL2 transcription. In the realm of pathway inhibitors, PD98059 and U0126, both MEK inhibitors, may enhance CHRDL2 function indirectly by influencing compensatory pathways. LY294002, a PI3K inhibitor, could also indirectly upregulate CHRDL2 by modifying AKT pathway dynamics. Lastly, L-ascorbic acid's support of collagen structure may affect extracellular matrix signaling, thereby potentially enhancing CHRDL2's functional activity in related cellular processes. These compounds, through their specific actions on signaling pathways and transcriptional regulation, collectively contribute to the functional activity enhancement of CHRDL2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, which increases intracellular levels of cAMP. Elevated cAMP activates PKA, which can phosphorylate transcription factors that enhance the expression of CHRDL2, thereby increasing its functional activity in cell signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP, leading to their accumulation. The increase in cAMP can result in the activation of PKA, which may then enhance CHRDL2 expression and activity as part of cellular response mechanisms. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to adrenergic receptors, which can lead to increased cAMP production and the subsequent activation of PKA. PKA activation can enhance CHRDL2 function by phosphorylation of transcription factors that upregulate CHRDL2 expression in cells. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 interacts with its EP receptors, leading to an increase in intracellular cAMP, which can activate PKA. PKA, in turn, can enhance CHRDL2 activity by upregulating its expression through the phosphorylation of relevant transcription factors within the cells. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can modulate transcription factor activation. The activation of JNK signaling can lead to the upregulation of CHRDL2 expression and functional activity by altering the transcriptional programs within the cells. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors (RARs) that modulate gene expression. RARs can enhance CHRDL2 function by directly influencing the transcription of genes, including those that may be involved in the pathway or cellular process that activates CHRDL2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a membrane-permeable cAMP analog that activates PKA. This activation can lead to enhanced CHRDL2 activity by upregulating its expression through PKA-mediated phosphorylation of transcription factors that control CHRDL2 gene transcription. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can lead to altered MAPK pathway signaling. By inhibiting MEK, CHRDL2's activity could be indirectly enhanced if CHRDL2 is involved in a negative feedback loop within the MAPK pathway, leading to increased CHRDL2 function in response to feedback regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can impact the AKT signaling pathway. By inhibiting PI3K, CHRDL2 activity could be indirectly enhanced if CHRDL2 is a part of the PI3K/AKT pathway, possibly by reducing negative feedback on factors that upregulate CHRDL2 expression. | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $46.00 | 5 | |
L-ascorbic acid, or Vitamin C, is an essential cofactor for collagen synthesis enzymes and may enhance CHRDL2 activity indirectly by stabilizing collagen structure and potentially influencing pathways that CHRDL2 is involved in, such as cell adhesion or signaling related to the extracellular matrix. | ||||||